Details: icmr, delhi along with university of oxford is proposing to conduct a multi-centre, adaptive platformtrial in covid-19 patients, titled ‘india-uk recovery (randomised evaluation of covid-19therapy).an expression of intent is sought from institutions/hospitals with the facilities and capacity available toparticipate in the above-mentioned clinical trial, which will enroll participants admitted in their hospitals.the intervention arm of the trial will include baricitinib. the control arm will receive local standard ofcare.the trial will be initiated only after obtaining requisite regulatory and ethics approvals. a brief synopsisof the study plan is attached herewith. institutions which are interested to collaborate with icmr onundertaking this trial, may express their interest by providing the details through the following lin
Sector: Medical Education